Paracetamol Kabi

Paracetamol, the active ingredient in Paracetamol Kabi, is an analgesic presented as an intravenous solution for intravenous use. It provides pain relief and reduces fever in adult and pediatric patients when administered by healthcare professionals. GNH USA supplies Paracetamol Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Paracetamol Kabi is an analgesic/antipyretic that acts on pain and fever pathways. - Mild to moderate pain: provides analgesia for postoperative, musculoskeletal and dental pain. - Fever: reduces elevated body temperature in febrile conditions. - Headache: alleviates tension‑type and migraine‑associated pain.

Paracetamol Kabi may be associated with several adverse reactions.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Transient hypotension: brief drop in blood pressure during administration. - Nausea: feeling of sickness or urge to vomit. - Vomiting: expulsion of stomach contents. - Mild rash: skin redness or itching. - Elevated liver enzymes: temporary increase in hepatic markers.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Severe hepatic injury: potential liver failure with high cumulative doses. - Blood dyscrasias: rare abnormalities in blood cell counts. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction. - Acute renal failure: sudden loss of kidney function. - Cardiovascular collapse: rare but life‑threatening drop in circulatory function.

Paracetamol Kabi should be used with attention to patient‑specific factors and handling requirements. - Renal impairment: monitor renal function and adjust use as needed. - Hepatic impairment: avoid high cumulative doses and assess liver enzymes regularly. - Alcohol consumption: limit intake to reduce risk of hepatotoxicity. - Concomitant hepatotoxic drugs: increase monitoring of liver function tests. - Pregnancy and lactation: use only when clearly indicated after risk‑benefit assessment. - Store at ambient temperature: keep in original container, protect from moisture and light.

Paracetamol Kabi can interact with other medicines, requiring careful review.

Major Interactions (Avoid): - Other paracetamol‑containing products: risk of overdose and liver toxicity. - Strong CYP450 inducers (e.g., rifampicin): may reduce analgesic efficacy. - Warfarin: may potentiate anticoagulant effect and increase bleeding risk.

Moderate Interactions (Monitor Closely): - Alcohol: enhances hepatotoxic potential. - Hepatotoxic drugs (e.g., isoniazid, methotrexate): monitor liver enzymes closely. - Antiepileptic drugs (e.g., carbamazepine, phenytoin): may alter paracetamol metabolism.